Disease-free interval | ||||
---|---|---|---|---|
Characteristics | ≤ 1 year | 1-3 years | ≥ 3 years | P a |
Age (years) | 0.018 | |||
≤ 45 | 39 (30.0) | 47 (36.2) | 44 (33.8) | |
> 45 | 53 (45.7) | 39 (33.6) | 24 (20.7) | |
Gender | 0.701 | |||
Male | 75 (38.3) | 66 (33.6) | 55 (28.1) | |
Female | 17 (34.0) | 20 (40.0) | 13 (26.0) | |
EBV VCA-lgAb | 0.624 | |||
≤ 320:1c | 35 (35.0) | 37 (37.0) | 28 (28.0) | |
>320:1 | 30 (42.9) | 22 (31.4) | 18 (25.7) | |
EBV EA-lgAb | 0.826 | |||
≤ 40:1d | 42 (37.5) | 38 (33.9) | 32 (28.6) | |
> 40:1 | 23 (39.7) | 21 (36.2) | 14 (24.1) | |
UICC T classification | 0.001 | |||
T1-2 | 25 (25.8) | 33 (34.0) | 39 (40.2) | |
T3-4 | 67 (45.0) | 53 (35.5) | 29 (19.5) | |
UICC N classification | 0.012 | |||
N0 | 10 (24.4) | 12 (29.3) | 19 (46.3) | |
N1-3 | 82 (40.0) | 74 (36.1) | 49 (23.9) |